JNJ logo

Johnson & Johnson (JNJ) Company Overview

Profile

Full Name:

Johnson & Johnson

Sector:

Healthcare

Industry:

Drug Manufacturers - General

Country:

United States

IPO:

January 2, 1943

Indexes:

S&P 500,Dow Jones

Website:

http://www.jnj.com

Description:

Johnson & Johnson is an American corporation consisting of three major divisions: consumer products, pharmaceuticals, and medical devices. Founded in 1886, the headquarters are in New Jersey. Johnson & Johnson produces a wide range of pharmaceuticals, body care products under the brand names JOHNSON'S Baby, Neutrogena, o.b., Carefree, Reach, Clean & Clear, RoC, Acuvue contact lenses, and others. The company also manufactures various materials, instruments, equipment, and technologies for medical institutions. It has more than 250 subsidiaries in over 60 countries and its products are sold in more than 175 countries.

Key Details

Price

$166.65

Market Cap

$401.23 B(Mega cap)

Last Dividend

$1.24

TTM Dividend Yield

2.98%

Annual Revenue

$88.82 B(+4.30% YoY)

Annual EPS

$5.79(-57.80% YoY)

PE Ratio

28.78

Annual ROE

20.06%

Annual Debt To Equity

0.51

Beta

-0.13

Events Calendar

Earnings

Next earnings date:

Apr 15, 2025

Recent quarterly earnings:

Jan 22, 2025

Recent annual earnings:

Jan 22, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Feb 18, 2025
Splits

Next split:

N/A

Recent split:

Jun 13, 2001

Analyst ratings

Recent major analysts updates

Mar 5, 25 B of A Securities
Neutral
Feb 19, 25 RBC Capital
Outperform
Feb 3, 25 Guggenheim
Neutral
Jan 28, 25 Barclays
Equal-Weight
Jan 23, 25 Wells Fargo
Equal-Weight
Jan 23, 25 Stifel
Hold
Jan 23, 25 Raymond James
Outperform
Jan 23, 25 RBC Capital
Outperform
Jan 23, 25 Morgan Stanley
Equal-Weight
Jan 23, 25 Leerink Partners
Outperform

Screeners with JNJ included

Highest dividend per share TTM in sector
US stocks
High Piotroski score stocks
S&P 500 companies earnings calendar
Most recommended stocks
Best performing stocks last 3 months
Best performing stocks last 5 years
Dow Jones companies
Stocks above SMA 50
S&P 500 companies

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$166.65
JNJ price is $166.65

Price All-time High

$186.01
JNJ price is currently -10.41% below its historical high of $186.01

Price Analysts Target

$166.37
JNJ price is currently +0.17% higher than the consensus analysts' forecast

Price Most Recent Change

+0.69%
JNJ price was up +0.69% on Mar 8, 2025

Price YTD Change

+15.25%
JNJ price is up +15.25% since January 1st

Price 3-Year Change

-3.23%
JNJ price is down -3.23% over the past 3 years

Market cap

Market Cap

$401.23 B
JNJ market capitalization is $401.23 billion

Market Cap 3-Year Change

-11.4%
JNJ market capitalization is down -11.4% over the past 3 years

Market Cap All-time High

$489.47 B
JNJ market capitalization is currently -18.03% below its historical high of $489.47 billion

Market Cap Sector Rank

99.84%
JNJ market capitalization is higher than 99.84% of companies in Healthcare sector

Technical

Beta

-0.13
JNJ beta is -0.13

200-day SMA

$155.03
JNJ price is currently +7.49% above its 200-day simple moving average

14-day RSI

68.27
JNJ 14-day relative strength index is 68.27

30-day Relative Volume

0.78
JNJ 30-day relative volume is 0.78

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$1.24
JNJ last dividend was $1.24 per share, with an ex-dividend date of February 18, 2025

Next Dividend

-
JNJ next dividend has not yet been announced

Dividend per share

Annual Dividend Per Share

$4.91
JNJ annual dividend per share is $4.91

Annual Dividend Per Share Sector Rank

91.57%
JNJ annual dividend per share is higher than 91.57% of companies in Healthcare sector

Annual Dividend Per Share 1-Year Change

+4.47%
JNJ annual dividend per share is up +4.47% year-on-year

Annual Dividend Per Share 3-Year Change

+17.18%
JNJ annual dividend per share is up +17.18% over the past 3 years

Dividend yield

Annual Dividend Yield

2.95%
JNJ annual dividend yield is 2.95%

Annual Dividend Yield Sector Rank

68.29%
JNJ annual dividend yield is higher than 68.29% of companies in Healthcare sector

Other

Annual Payout Ratio

84.05%
JNJ annual payout ratio is 84.05%

Annual Dividends Paid

$11.82 B
JNJ annual dividends paid is $11.82 billion

Annual FCF

$18.06 B
JNJ annual free cash flow is $18.06 billion

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$88.82 B
JNJ annual revenue is $88.82 billion

Annual Revenue Analysts Estimate

$89.96 B
JNJ annual revenue is currently -1.27% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+4.3%
JNJ annual revenue is up +4.3% year-on-year

Annual Revenue Sector Rank

98.92%
JNJ annual revenue is higher than 98.92% of companies in Healthcare sector

Profit

Annual Gross Profit

$61.35 B
JNJ annual gross profit is $61.35 billion

Annual Gross Margin

69.07%
JNJ annual gross profit margin is 69.07%

Annual Operating Profit

$21.25 B
JNJ annual operating income is $21.25 billion

Annual Operating Margin

23.92%
JNJ annual operating profit margin is 23.92%

Annual Net Income

$14.07 B
JNJ annual net profit is $14.07 billion

Annual Net Margin

15.84%
JNJ annual net profit margin is 15.84%

EPS

Annual EPS

$5.79
JNJ annual earnings per share is $5.79

Annual EPS Analysts Estimate

$10.57
JNJ annual earnings per share is currently -45.21% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

-57.8%
JNJ annual earnings per share is down -57.8% year-on-year

Annual EPS Sector Rank

96.13%
JNJ annual earnings per share is higher than 96.13% of companies in Healthcare sector

ROA & ROE

Annual ROA

8.09%
JNJ annual return on assets is 8.09%

Annual ROE

20.06%
JNJ annual return on equity is 20.06%

EBIT & EBITDA

Annual EBIT

$21.25 B
JNJ annual earnings before interest & taxes is $21.25 billion

Annual EBITDA

$21.25 B
JNJ annual EBITDA is $21.25 billion

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

28.78
JNJ price to earnings ratio is 28.78

PE Ratio Sector Rank

53.69%
JNJ price to earnings ratio is higher than 53.69% of companies in Healthcare sector

PB Ratio

PB Ratio

5.61
JNJ price to book ratio is 5.61

PB Ratio Sector Rank

84.93%
JNJ price to book ratio is higher than 84.93% of companies in Healthcare sector

PS Ratio

PS Ratio

4.52
JNJ price to sales ratio is 4.52

PS Ratio Sector Rank

60.37%
JNJ price to sales ratio is higher than 60.37% of companies in Healthcare sector

Enterprise value

Enterprise Value

$413.76 B
JNJ enterprise value is $413.76 billion

Enterprise Value Sector Rank

99.75%
JNJ enterprise value is higher than 99.75% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

18.39
JNJ EV/EBITDA is 18.39

EV/EBITDA Sector Rank

89.4%
JNJ EV/EBITDA is higher than 89.4% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

1.11
JNJ annual current ratio is 1.11

Annual Quick Ratio

0.86
JNJ annual quick ratio is 0.86

Leverage

Annual Debt To Equity

0.51
JNJ annual debt to equity ratio is 0.51

Annual Interest Coverage Ratio

28.14
JNJ annual interest coverage ratio is 28.14

Risk & Stability

Piotroski F-Score

6
JNJ piotroski f-score is 6

Altman Z-Score

-
JNJ altman z-score value is unknown

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$180.10 B
JNJ annual total assets is $180.10 billion

Annual Non Current Assets

$124.21 B
JNJ annual long term assets is $124.21 billion

Annual Current Assets

$55.89 B
JNJ annual total current assets is $55.89 billion

Annual Cash & Cash Equivalents

$24.11 B
JNJ annual cash & cash equivalents is $24.11 billion

Equity

Annual Book Value

$71.49 B
JNJ annual book value is $71.49 billion

Annual Working Capital

$5.57 B
JNJ annual working capital is $5.57 billion

Liabilities

Annual Total Liabilities

$108.61 B
JNJ annual total liabilities is $108.61 billion

Annual Total Long Term Liabilities

$58.29 B
JNJ annual total long term liabilities is $58.29 billion

Annual Current Liabilities

$50.32 B
JNJ annual total current liabilities is $50.32 billion

Annual Accounts Payable

$10.31 B
JNJ annual accounts payable is $10.31 billion

Debt

Annual Total Debt

$36.63 B
JNJ annual total debt is $36.63 billion

Annual Total Debt 1-Year Change

+24.89%
JNJ annual total debt is up +24.89% year-on-year

Annual Long Term Debt

$30.65 B
JNJ annual long term debt is $30.65 billion

Annual Short Term Debt

$5.98 B
JNJ annual short term debt is $5.98 billion

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$67.57 B
JNJ annual total expenses is $67.57 billion

Annual Operating Expenses

$40.10 B
JNJ annual total operating expenses is $40.10 billion

Annual Cost Of Goods Sold

$27.47 B
JNJ annual cost of goods sold is $27.47 billion

Annual SGA

$22.87 B
JNJ annual SGA is $22.87 billion

Annual D&A

$7.34 B
JNJ annual depreciation & amortization is $7.34 billion

Annual Interest Expense

$755.00 M
JNJ annual interest expense is $755.00 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$24.27 B
JNJ annual cash flow from operations is $24.27 billion

Annual CFO 1-Year Change

+6.47%
JNJ annual cash flow from operations is up +6.47% year-on-year

Annual CFI

-$18.60 B
JNJ annual cash flow from investing activities is -$18.60 billion

Annual CFI 1-Year Change

-2218.34%
JNJ annual cash flow from investing activities is down -2218.34% year-on-year

Annual CFF

-$3.13 B
JNJ annual cash flow from financing activities is -$3.13 billion

Annual CFF 1-Year Change

+80.21%
JNJ annual cash flow from financing activities is up +80.21% year-on-year

Free CashFlow

Annual FCF

$18.06 B
JNJ annual free cash flow is $18.06 billion

Annual FCF 1-Year Change

+1.58%
JNJ annual free cash flow is up +1.58% year-on-year

CAPEX

Annual CAPEX

$6.21 B
JNJ annual capital expenditures is $6.21 billion

Annual CAPEX 1-Year Change

+23.82%
JNJ annual capital expenditures is up +23.82% year-on-year

Institutional Ownership

Similar stocks

NVO logo
Novo Nordisk A/S (NVO)
ABBV logo
AbbVie (ABBV)
UNH logo
UnitedHealth Group Incorporated (UNH)
AZN logo
AstraZeneca (AZN)
MRK logo
Merck & Co (MRK)
ABT logo
Abbott Laboratories (ABT)
NVS logo
Novartis AG (NVS)
TMO logo
Thermo Fisher Scientific (TMO)
ISRG logo
Intuitive Surgical (ISRG)

FAQ

  • What is the ticker symbol for Johnson & Johnson?
  • Does Johnson & Johnson pay dividends?
  • What sector is Johnson & Johnson in?
  • What industry is Johnson & Johnson in?
  • What country is Johnson & Johnson based in?
  • When did Johnson & Johnson go public?
  • Is Johnson & Johnson in the S&P 500?
  • Is Johnson & Johnson in the NASDAQ 100?
  • Is Johnson & Johnson in the Dow Jones?
  • When was Johnson & Johnson's last earnings report?
  • When does Johnson & Johnson report earnings?
  • Should I buy Johnson & Johnson stock now?

What is the ticker symbol for Johnson & Johnson?

The ticker symbol for Johnson & Johnson is NYSE:JNJ

Does Johnson & Johnson pay dividends?

Yes, Johnson & Johnson pays dividends. The last payment was $1.24, with an ex-dividend date on February 18, 2025

What sector is Johnson & Johnson in?

Johnson & Johnson is in the Healthcare sector

What industry is Johnson & Johnson in?

Johnson & Johnson is in the Drug Manufacturers - General industry

What country is Johnson & Johnson based in?

Johnson & Johnson is headquartered in United States

When did Johnson & Johnson go public?

Johnson & Johnson's initial public offering (IPO) was on January 2, 1943

Is Johnson & Johnson in the S&P 500?

Yes, Johnson & Johnson is included in the S&P 500 index

Is Johnson & Johnson in the NASDAQ 100?

No, Johnson & Johnson is not included in the NASDAQ 100 index

Is Johnson & Johnson in the Dow Jones?

Yes, Johnson & Johnson is included in the Dow Jones index

When was Johnson & Johnson's last earnings report?

Johnson & Johnson's most recent earnings report was on Jan 22, 2025

When does Johnson & Johnson report earnings?

The next expected earnings date for Johnson & Johnson is Apr 15, 2025

Should I buy Johnson & Johnson stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions